JetBlue Airways heads into its May 14 Q1 results with nearly one in five shares of the float sold short — and with that position quietly expanding week by week, despite a market that staged a partial tariff-relief rally around the airline sector in April.
Short interest is the clearest story here. At 20.9% of free float, the position is large and grinding higher — up roughly 2% on the week and 6% over the past month. The trajectory tells a specific story: between mid-March and early April, shorts climbed from around 19% to above 22%, then pulled back sharply after April 10, likely as the broader tariff relief bounce played out. Since then the position has stabilised in a 20–21% band and resumed inching upward. The ORTEX short score of 63.7 ranks in just the 9th percentile of the broader universe, placing JetBlue firmly among the more heavily bet-against names in the market. Days to cover runs at 2.9, meaning shorts carry limited covering pressure in normal conditions.
The borrow market tells a more relaxed side of the same story. Cost to borrow has crept up about 19% on the week to 0.51% APR — still very cheap to borrow, and well within the range of the past six months. Availability remains wide, with roughly 35% of borrowed shares still available for new shorts to access. That combination — high short interest but affordable, available borrow — points to a position that is large and persistent, not a forced squeeze candidate. Options add a mild defensive tilt: the put/call ratio is 0.81, slightly above its 20-day average of 0.80, with a z-score of just 0.36. Options markets are neither notably bearish nor rushing to hedge — the stance is measured.
The Street's direction has been consistently downward since February's brief burst of optimism. In late January and early February, JPMorgan, Evercore, and Citigroup all lifted targets into the $5–$6 range and Barclays upgraded to Equal-Weight with a $7 target. Since then almost every firm has reversed: Citi trimmed back to $4.40 in March, Goldman (maintaining a Sell) cut to $3.50 in April, and UBS sits at $3.50 as well. The consensus mean target is now $4.72 — essentially in line with Wednesday's close of $4.84, pointing to a Street that sees little upside and some downside risk. EPS momentum is an outlier in the other direction: the 30-day and 90-day EPS momentum ranks at the 97th and 98th percentiles respectively, meaning forward earnings estimates have been rising aggressively relative to the rest of the market. That divergence between analyst price targets moving lower and forward EPS estimates moving higher is the central tension in this setup.
Institutional ownership adds one notable element. Icahn Capital holds 9% of shares outstanding, reported as of year-end 2025 with no change — a large, unmoved block that has sat through the stock's extended weakness. Angelica Galkin Revocable Trust added roughly 3.4 million shares recently and now holds 9.5%. BlackRock and Vanguard account for a combined 20% and made only incremental adjustments in the March quarter. Insider activity in April was dominated by equity award grants paired with same-day tax-related sells: the president, COO, and CTO all participated in this pattern at prices around $4.93. The 90-day net insider value is modestly positive at $1.4 million, but that reflects awards rather than discretionary buying — not a particularly strong signal of conviction at current levels.
JetBlue closed Wednesday at $4.84, down 3.2% on the day and nearly 5% on the week, underperforming close peers — AAL fell 1.7% on the week, DAL dropped 3.1%, while ALGT and ALK shed 7.6% and 6.1% respectively. JetBlue's move was roughly mid-pack in a sector under broad pressure. The stock is still up 14.7% over the past month, preserving most of the tariff-relief bounce. The EV/EBITDA multiple has expanded by 5.6 turns over the past month to 16.8x — a notable re-rating for a carrier still posting negative earnings. The May 14 earnings print arrives as the market's key decision point: whether the aggressive upward revision in forward EPS estimates reflects something real, or whether the analysts cutting price targets are closer to the truth.
See the live data behind this article on ORTEX.
Open JBLU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
